Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00410761 · BASELINE

Baseline characteristics

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer · Source last updated 2025-09-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      231
    2. group Id
      BG001
      value
      100
    3. group Id
      BG002
      value
      331
    units
    Participants
groups
  1. description
    Vandetanib (300 mg daily)
    id
    BG000
    title
    Vandetanib 300 mg
  2. description
    Placebo daily
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          18
          upper Limit
          83
          value
          50.7
        2. group Id
          BG001
          lower Limit
          26
          upper Limit
          84
          value
          53.4
        3. group Id
          BG002
          lower Limit
          18
          upper Limit
          84
          value
          52
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          97
        2. group Id
          BG001
          value
          44
        3. group Id
          BG002
          value
          141
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          134
        2. group Id
          BG001
          value
          56
        3. group Id
          BG002
          value
          190
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
The full analysis set included all randomized participants.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      231
    2. group Id
      BG001
      value
      100
    3. group Id
      BG002
      value
      331
    units
    Participants
groups
  1. description
    Vandetanib (300 mg daily)
    id
    BG000
    title
    Vandetanib 300 mg
  2. description
    Placebo daily
    id
    BG001
    title
    Placebo
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          18
          upper Limit
          83
          value
          50.7
        2. group Id
          BG001
          lower Limit
          26
          upper Limit
          84
          value
          53.4
        3. group Id
          BG002
          lower Limit
          18
          upper Limit
          84
          value
          52
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          97
        2. group Id
          BG001
          value
          44
        3. group Id
          BG002
          value
          141
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          134
        2. group Id
          BG001
          value
          56
        3. group Id
          BG002
          value
          190
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
The full analysis set included all randomized participants.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice